Your activity: 2 p.v.
Why UpToDate?
What's New
Patient Education
Calculators
Drug interactions
Subscribe
Log In
< Back
Uptodate Reference Title
Go To Link
Close
Risk* of late pulmonary toxicity other than pulmonary embolus after four courses of BEP in the Danish Testicular Cancer Registry series
Risk* of late pulmonary toxicity other than pulmonary embolus after four courses of BEP in the Danish Testicular Cancer Registry series
Toxicity
BEP (n = 565)
No BEP (n = 2548)
Pulmonary fibrosis
3 (0.4%)
5 (0.2%)
Obstructive pulmonary disease
15 (3.3%)
72 (2.8%)
Pneumonia
15 (2.6%)
103 (3.3%)
Pneumothorax
2 (0.3%)
6 (0.4%)
BEP: bleomycin, etoposide, cisplatin.
* 15-year cumulative risk, with time at risk calculated one year from the treatment start.
From: Lauritsen J, Kier MG, Bandak M, et al. Pulmonary function in patients with germ cell cancer treated With Bleomycin, Etoposide, and Cisplatin. J Clin Oncol 2016; 34(13):1492-9. Reprinted with permission. Copyright © 2016 American Society of Clinical Oncology. All rights reserved.
Graphic 107640 Version 4.0